Back to Agenda
R&D and Technology Outsourcing Today: An Industry Update
Session Chair(s)
Keith Wenzel
Volunteer, DIA Study Endpoints Community, United States
This session will explore the current trends in outsourcing from large strategic to functional sourcing to technology partnerships, as well as identify new trends and hear perspectives about the future of outsourcing.
Learning Objective : Discuss the most prevalent models today for R&D and associated technology outsourcing; Describe the resulting benefits and challenges for the various partnering models; Identify new trends in outsourcing and hear perspectives about the future of outsourcing.
Speaker(s)
Heather Zigmund, PHARMD
Senior Director, Global Head of Study Management Early Stage Development BioPhar, AstraZeneca, United States
CRO Perspective
Esther Sadler-Williams, MPHARM, MSC, RPH
Global Director, Strategic Development and Innovation, Catalent Pharma Solutions, Inc., United Kingdom
CMO Perspective
Keith E. Anderson, PHD
Vice President, Pharmaceutical Sciences, Seragon Pharmaceuticals, United States
Pharmaceutical Perspective on Outsourcing Trends
Have an account?